EDGAR Filing Documents for 0001564590-18-005459

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001564590-18-005459

Filing Date

2018-03-13

Accepted

2018-03-13 16:01:25

Documents

Period of Report

2017-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	atrs-10k_20171231.htm	10-K	3167458
2	EX-23.1	atrs-ex231_10.htm	EX-23.1	3062
3	EX-31.1	atrs-ex311_9.htm	EX-31.1	15707
4	EX-31.2	atrs-ex312_7.htm	EX-31.2	15825
5	EX-32.1	atrs-ex321_6.htm	EX-32.1	6448
6	EX-32.2	atrs-ex322_8.htm	EX-32.2	6365
7	GRAPHIC	g201803131457549085094.jpg	GRAPHIC	37854
	Complete submission text file	0001564590-18-005459.txt		9195929

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	atrs-20171231.xml	EX-101.INS	1888965
9	XBRL TAXONOMY EXTENSION SCHEMA	atrs-20171231.xsd	EX-101.SCH	52035
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	atrs-20171231_cal.xml	EX-101.CAL	68991
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	atrs-20171231_def.xml	EX-101.DEF	146752
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	atrs-20171231_lab.xml	EX-101.LAB	430755
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	atrs-20171231_pre.xml	EX-101.PRE	325325

Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628

Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020

ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)